SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-274452
Filing Date
2020-10-22
Accepted
2020-10-22 16:43:00
Documents
5
Period of Report
2020-12-09
Effectiveness Date
2020-10-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d140459ddef14a.htm DEF 14A 393388
2 GRAPHIC g140459g10p21.jpg GRAPHIC 27860
3 GRAPHIC g140459g13m07.jpg GRAPHIC 36973
4 GRAPHIC g140459g47s71.jpg GRAPHIC 220168
5 GRAPHIC g140459g69r16.jpg GRAPHIC 400662
  Complete submission text file 0001193125-20-274452.txt   1329188
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39267 | Film No.: 201255290
SIC: 2834 Pharmaceutical Preparations